UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation

Nature (London), 2017-06, Vol.546 (7659), p.549-553

2017

Volltextzugriff (PDF)

Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial

Journal of allergy and clinical immunology, 2015-07, Vol.136 (1), p.116-124.e7

2015

Volltextzugriff (PDF)

Computer-aided classification of melanocytic lesions using dermoscopic images

Journal of the American Academy of Dermatology, 2015-11, Vol.73 (5), p.769-776

2015

Volltextzugriff (PDF)

COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence

Journal of the American Academy of Dermatology, 2021-11, Vol.85 (5), p.1274-1284

2021

Volltextzugriff (PDF)

Short and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data

Journal of the American Academy of Dermatology, 2017-03, Vol.76 (3), p.432-440.e17

2017

Volltextzugriff (PDF)

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

BMC cancer, 2018-02, Vol.18 (1), p.130-130, Article 130

2018

Volltextzugriff (PDF)

Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy

Journal of the American Academy of Dermatology, 2015-05, Vol.72 (5), p.780-785.e3

2015

Volltextzugriff (PDF)

Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification

Journal of the American Academy of Dermatology, 2017-05, Vol.76 (5), p.818-825.e3

2017

Volltextzugriff (PDF)

Early Detection of Melanoma: Rethinking the Outcomes That Matter

JAMA dermatology (Chicago, Ill.), 2021-05, Vol.157 (5), p.511

Ferris, Laura K.

2021

Volltextzugriff (PDF)

Reply to: “Computer-aided classification of melanocytic lesions using dermoscopic images: Low reported accuracy for reader study on melanomas with low melanoma in situ to invasive melanoma ratio”

Journal of the American Academy of Dermatology, 2016-09, Vol.75 (3), p.e121-e121

2016

Volltextzugriff (PDF)

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

Dermatology and therapy, 2020-06, Vol.10 (3), p.431-447

2020

Volltextzugriff (PDF)

Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis

Clinical and translational science, 2024-01, Vol.17 (1), p.e13682-n/a

2024

Volltextzugriff (PDF)

Electrophilic nitro-fatty acids suppress psoriasiform dermatitis: STAT3 inhibition as a contributory mechanism

Redox biology, 2021-07, Vol.43, p.101987-101987, Article 101987

2021

Volltextzugriff (PDF)

Teledermatology isotretinoin management for moderate-to-severe acne reveals similar outcomes to in-person management: A retrospective study

JAAD international, 2023-06, Vol.11, p.126-128

2023

Volltextzugriff (PDF)

BAP1 regulates IP3R3-mediated Ca 2+ flux to mitochondria suppressing cell transformation

Nature (London), 2017-06, Vol.546 (7659), p.549

2017

Volltextzugriff (PDF)

The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study

Journal of the American Academy of Dermatology, 2017-10, Vol.77 (4), p.667-674

2017

Volltextzugriff (PDF)

Dermatology medications with the highest cost burden on Medicare Part D: Potential implications of the Inflation Reduction Act

Journal of the American Academy of Dermatology, 2024-08, Vol.91 (2), p.379-381

2024

Volltextzugriff (PDF)

Psychosocial consequences of skin cancer screening

Preventive medicine reports, 2018-06, Vol.10, p.310-316

2018

Volltextzugriff (PDF)

Skin Biopsies and Diagnostic Outcomes at a Multisite Family Medicine Residency Network

Southern medical journal (Birmingham, Ala.), 2024-10, Vol.117 (10), p.609-611

2024

Volltextzugriff (PDF)

Development and Narrow Validation of Computer Vision Approach to Facilitate Assessment of Change in Pigmented Cutaneous Lesions

JID innovations, 2023-03, Vol.3 (2), p.100181, Article 100181

2023

Volltextzugriff (PDF)

An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis

The New England journal of medicine, 2024-02, Vol.390 (6), p.510-521

2024

Volltextzugriff (PDF)

Prevalence of Total Body Skin Examinations among Dermatology Encounters in Medicare Data: A Retrospective Cohort Study

Journal of investigative dermatology, 2024-04, Vol.144 (4), p.905-908.e16

2024

Volltextzugriff (PDF)

Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States

Journal of the American Academy of Dermatology, 2020-04, Vol.82 (4), p.1023-1024

2020

Volltextzugriff (PDF)

Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical Companies

JAMA dermatology (Chicago, Ill.), 2020-10, Vol.156 (10), p.1136

2020

Volltextzugriff (PDF)

ChatRx: ChatGPT’s potential to educate patients on medication adverse effects

Journal of the American Academy of Dermatology, 2024-03, Vol.90 (3), p.669-670

2024

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

ThemaSkin Neoplasms - Diagnosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Englisch
(169)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation

Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial

Computer-aided classification of melanocytic lesions using dermoscopic images

COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence

Short and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy

Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification

Early Detection of Melanoma: Rethinking the Outcomes That Matter

Reply to: “Computer-aided classification of melanocytic lesions using dermoscopic images: Low reported accuracy for reader study on melanomas with low melanoma in situ to invasive melanoma ratio”

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis

Electrophilic nitro-fatty acids suppress psoriasiform dermatitis: STAT3 inhibition as a contributory mechanism

Teledermatology isotretinoin management for moderate-to-severe acne reveals similar outcomes to in-person management: A retrospective study

BAP1 regulates IP3R3-mediated Ca 2+ flux to mitochondria suppressing cell transformation

The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study

Dermatology medications with the highest cost burden on Medicare Part D: Potential implications of the Inflation Reduction Act

Psychosocial consequences of skin cancer screening

Skin Biopsies and Diagnostic Outcomes at a Multisite Family Medicine Residency Network

Development and Narrow Validation of Computer Vision Approach to Facilitate Assessment of Change in Pigmented Cutaneous Lesions

An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis

Prevalence of Total Body Skin Examinations among Dermatology Encounters in Medicare Data: A Retrospective Cohort Study

Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States

Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical Companies

ChatRx: ChatGPT’s potential to educate patients on medication adverse effects

Aktive Filter

Suchergebnisse filtern